ACL injury prevention program for 17–20-year-old athletes in Brno
Anterior Cruciate Ligament Injury Prevention Program ESSKA/ESMA: A Comprehensive Approach to Reducing the Incidence of Knee Joint Injuries in Czech Sport
This project will try a structured ESSKA/ESMA 'ACL Prevention for ALL' program with targeted exercises and 2D motion analysis to reduce ACL injuries in 17–20-year-old athletes who play high-risk sports.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 17 Years to 20 Years |
| Sex | All |
| Sponsor | Masaryk University Academic / other |
| Locations | 1 site (Brno) |
| Trial ID | NCT07019727 on ClinicalTrials.gov |
What this trial studies
The program implements the evidence-based 'ACL Prevention for ALL' approach focused on muscle strengthening, flexibility, coordination, and safe movement technique delivered by a multidisciplinary team of coaches, physiotherapists, and physicians. Participants follow targeted exercise modules and education sessions, and undergo dynamic evaluations including 2D motion analysis of jumps and landings to identify biomechanical and muscle imbalances. Individualized training plans are created from the assessment data to correct deficits and improve movement safety. The project is carried out at Masaryk University and affiliated hospitals in Brno with the aim of reducing ACL injury incidence among adolescent athletes.
Who should consider this trial
Good fit: Ideal candidates are 17–20-year-old athletes engaged in sports with a high risk of ACL injury who have no current disabling knee injury, can attend regular training and testing sessions, and can provide informed consent.
Not a fit: Those with a current knee injury requiring treatment or surgery, significant chronic medical or neuromuscular conditions, or who cannot participate regularly are unlikely to benefit from the prevention program.
Why it matters
Potential benefit: If successful, the program could substantially lower ACL injury risk, improve movement safety, and help athletes continue sports with fewer knee problems.
How similar studies have performed: Similar implementations of the ‘ACL Prevention for ALL’ concept have demonstrated large reductions in ACL injuries (approximately 50–60%) across ages and competition levels, so the approach is supported by prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age group: Participants aged 17-20 years Sports activity: Individuals actively engaged in sports with a high risk of ACL injury Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians Exclusion Criteria: Current injury: Individuals with a current knee joint injury requiring treatment or surgery Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases) Insufficient consent: Individuals who are unable or unwilling to provide written informed consent Irregular participation: Individuals who do not comply with regular participation in the training program or assessments
Where this trial is running
Brno
- Faculty of Medicine, Masaryk University — Brno, Czechia (Recruiting)
Study contacts
- Study coordinator: Michael Lujc, MUDr.
- Email: lujc.michael@fnbrno.cz
- Phone: 722101065
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.